Skip to content

News

News

Stories, statements and updates from Rett Syndrome Europe and our member associations across Europe.

  • Eye Got the Power: Milestones and Miracles in Our Rett Family’s Communication Journey

    Eye Got the Power: Milestones and Miracles in Our Rett Family’s Communication Journey

    By Usree Bhattacharya It is poignant to me that the only video I have of my little girl, Kalika, speaking by mouth is the one in which she repeats after me: “I. Love. You.” When I captured that moment with my phone many years ago, I had no idea that it would be the last…

    Read →

  • Latest Update From Taysha Gene Therapy Programme

    Latest Update From Taysha Gene Therapy Programme

    News on the first patient dosed with their gene therapy and next steps in respect of expanding the trials…

    Read →

  • Latest Update From Taysha Gene Therapy Programme

    Latest Update From Taysha Gene Therapy Programme

    Taysha have shared the news today that they have been given the all clear to continue with their plans to dose the second adult with Rett syndrome in their gene therapy trial in Canada. You can read their letter here.

    Read →

  • Overview of the Network Support and Research event 2023

    Overview of the Network Support and Research event 2023

    RSE board are very pleased to present an overview of the March 2023 Network Support and Research event (see the document below). We would particularly like to draw your attention to the outcomes and action plans for each country that participated. In addition, since the event, the presentations have been translated into Spanish, Italian, Finnish,…

    Read →

  • CGPMax supplement

    CGPMax supplement

    We have been made aware of this product, a natural supplement to support brain health, by a parent of a girl with Rett syndrome in Spain whose daughter has been taking it. The product has been developed for the aged population and not specifically to help with Rett syndrome. It has not been subject to…

    Read →

  • A football match to raise funds and promote awareness of Rett syndrome

    A football match to raise funds and promote awareness of Rett syndrome

    Our new member from Spain – Mi Princesa Rett – are organising a football event with the “Legends of the Spanish national team” and the “Legends of the Badajoz football team” on the 30th of June 2023 at 21h. Mi Princesa Rett is a charity foundation based in Badajoz, Spain, dedicated to raising awareness and…

    Read →

  • Wearable devices to capture sleep problems

    Wearable devices to capture sleep problems

    Today we would like to share an interesting article that discusses the challenges of studying sleep problems in autistic people. Historically, research participants have had to sleep in a lab while connected to cumbersome equipment such as polysomnography, which can be uncomfortable and interfere with sleep, particularly for someone with autism who may also have…

    Read →

  • The Burden of Illness Study in Rett Syndrome

    The Burden of Illness Study in Rett Syndrome

    Following our Network Support and Research Event we would like to share a video of Walter Kaufmann presentation “Burden of Illness in Rett Syndrome: Initial Evaluation of a Disorder-Specific Caregiver Survey”. In this talk, Walter Kaufmann will present an overview of the Burden of Illness in Rett Syndrome survey. Previous studies have shown that individuals…

    Read →

  • Update from Anavex Life Sciences clinical trial

    Update from Anavex Life Sciences clinical trial

    Anavex Life Sciences Corp. announced the completion of the ANAVEX®2-73 (blarcamesine) U.S. Phase 2 study in Rett syndrome. The Company expects to announce topline results from this study in the next quarter. ANAVEX®2-73 is an orally available, small-molecule activator of the sigma-1 receptor which, data suggest, is pivotal to restoring neural cell homeostasis and promoting…

    Read →

  • Taysha administered the first dose of investigational gene therapy drug

    Taysha administered the first dose of investigational gene therapy drug

    These are definitely exciting and hopeful times for Rett community. Taysha Gene Therapies have announced that the first patient was dosed with the investigational gene therapy, TSHA-102, in the REVEAL Adult Study, a clinical trial for females 18 years and older living with Rett syndrome. As things move forward, we´d like to share the letter…

    Read →

Stay connected

Follow Rett Syndrome Europe

For the latest stories, events and research updates, follow us on social media.